Business
Adaptive Biotechnologies applies immune-system sequencing and computational biology to minimal residual disease testing and immune medicine.
Adaptive grew revenue 55%, lifted gross margin, and cut burn, but insider selling was heavy.
The read at a glance✓ Audited against SEC data
- Business mix — MRD and immune medicine platformNote
- Revenue — Revenue +54.8% to $277.0MOK
- Profitability — Net loss improved to $59.5MOK
- Cash burn — Free cash flow improved to -$48.9MOK
- Balance sheet — Equity +7.9% to $218.8MOK
- Insiders — 0 buys / 82 sellsWatch
- Accounting — Altman-Z distress; EQ safeWatch
Where the revenue comes from
Fiscal 2025, as Adaptive Biotechnologies Corp reports it. History and quarterly detail are in the app.
- Mrd Business$212.3M
- Immune Medicine Business$64.6M
Leadership changes
From Adaptive Biotechnologies Corp's own filings, the day they're filed.
- Kyle Piskel · Chief Financial Officer · appointmenteff. 2024-04-08
- Tycho Peterson · Chief Financial Officer · departureeff. 2024-04-01
- Kevin Conroy · Directors · departureeff. 2023-09-01
Latest filings
- 10-Q · Quarterly report2026-08-04
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-06-22
- 8-K · Company announcement2026-06-15
- 8-K · Company announcement2026-06-09
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Adaptive Biotechnologies Corp, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.